---
category: news
title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"
excerpt: "“As each patient’s cancer is unique, we have developed a therapy that turns their ... from its world-leading expertise in artificial intelligence and its unique algorithm that is used to ..."
publishedDateTime: 2020-01-07T00:12:00Z
sourceUrl: https://www.businesswire.com/news/home/20200106006021/en/Transgene-NEC-Start-Clinical-Trials-TG4050-AI-Powered
type: article
quality: 14
heat: 14
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI
  - AI in Healthcare

images:
  - url: https://mms.businesswire.com/media/20200106006021/en/765262/23/NEC.jpg
    width: 1200
    height: 627
    title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"

secured: "S4sLLngnakgdWq8NaQw2cSIlRVFK3eXGVW5LhBc6s6BHAJxeUEEu0lPLSwBhMz/d4jW2je7n7l4ZNS3JdtVr2WiH2qPeKaIX5tDZzVvqrh9YPj3u3wf0TYMTH4mvDK4LfEopF/If1mG54o46974mbLQoDc3x7YyNx4+nkN45LPj39vz/7T5cojVzPvUk7MGC+JeDi9HcnjKlvqGENw1j5/TU1YqMZSuVJE33W8tRM5VDyU4Zm0AbkOtZSHOWIrhcjsS4otYutq5VuyXUJgpvB5Jz0l49AgDx8o0THL+focB+qAhM8E071Uzjmvw2yRbb;QkX0tFlMH3xG9ADGESvH0g=="
---

